Skip to content
MedBiz Pro

e-mail: info@medbizpro.com
  • News
  • Blog Zone
  • Contact
  • sr
MedBiz Pro > Oglasi > Vračar, Hram, poslovni prostor 60m2

Vračar, Hram, poslovni prostor 60m2

Posted on 01/06/201801/06/2018 by Mila

http://rajicnekretnine.rs/1070-vracar-hram-poslovni-prostor-60m2

Posted in Oglasi
Post navigation
Health Tip: When Baby Spits Up →
← Mediterranean Diet Scores Again for Heart Health

News

  • EULAR publishes updated recommendations for SLE management
    on 09/12/2023 at 4:49 am

    SLE is a heterogeneous disease, which can cause many different manifestations and symptoms, and traditionally did not have many treatment options.

  • Women over 50 can safely reduce mammogram frequency after breast cancer surgery
    on 09/12/2023 at 4:43 am

    Women 50 or older who de-escalated to less-frequent mammography three years after curative surgery for early-stage breast cancer had similar outcomes to women who received annual mammography, according to results from the Mammo-50 trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.

  • Low-risk DCIS patients may safely skip radiotherapy after surgery, study finds
    on 09/12/2023 at 4:03 am

    Patients with low-risk ductal carcinoma in situ (DCIS) who skipped adjuvant radiotherapy after breast-conserving surgery had comparable five-year outcomes to those with high-risk DCIS who received adjuvant radiotherapy, according to results from the E4112 clinical trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.

  • MD Anderson and Rigel partner to expand olutasidenib evaluation in AML and other cancers
    on 09/12/2023 at 3:48 am

    The University of Texas MD Anderson Cancer Center and Rigel Pharmaceuticals, Inc. today announced a multi-year strategic development collaboration to expand the evaluation of olutasidenib in acute myeloid leukemia (AML) and other hematologic cancers.

  • New insights into how anti-obesity drugs could help prevent kidney disease
    on 09/12/2023 at 3:28 am

    Data from Australian researchers could partly explain why a trial of a new drug for diabetes, was recently halted because it was found to be so effective.

  • Brain activity measured in living tissue using diamond sensors
    on 09/12/2023 at 3:01 am

    A recent study by European scientists shows that highly sensitive sensors based on color centers in a diamond can be used to record electrical activity from neurons in living brain tissue.

  • Expanding the toolbox for drug design: New enzymes for tailoring molecules
    on 09/12/2023 at 2:01 am

    Simon Schröder has worked out how enzymes can be used to more easily form the desired bond between two nitrogen atoms.

  • Study identifies targetable fusion RNAs in breast cancer
    on 09/12/2023 at 1:28 am

    Comprehensive profiling of fusion RNAs present in a large cohort of metastatic breast tumors revealed unique fusion mutations that may be therapeutically targetable, according to results presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.

  • New guidelines offer hope for fatigue management in people with inflammatory RMD
    on 09/12/2023 at 12:47 am

    Fatigue is common in people with inflammatory rheumatic and musculoskeletal diseases(RMD). The causes of fatigue are not well understood, and it is likely that they vary between people and over time.

  • Study unlock secrets of Zika virus's multipurpose enzyme and reveals therapeutic vulnerability
    on 09/12/2023 at 12:40 am

    Viruses have limited genetic material-;and few proteins-;so all the pieces must work extra hard. Zika is a great example; the virus only produces 10 proteins.

  • Fully-automated, CT-only GTV contouring for palliative head and neck radiotherapy
    on 09/12/2023 at 12:00 am
  • Oxidation-treated carbon nanotube yarns accelerate neurite outgrowth and induce axonal regeneration in peripheral nerve defect
    on 09/12/2023 at 12:00 am
  • Substitution of arginine 219 by glycine compromises stability, dimerization, and catalytic activity in a G6PD mutant
    on 09/12/2023 at 12:00 am
  • Prediction of osteoporosis in patients with rheumatoid arthritis using machine learning
    on 09/12/2023 at 12:00 am
  • SABCS: Outcomes No Worse for Survivors With Less Frequent Mammograms
    on 08/12/2023 at 9:48 pm

    FRIDAY, Dec. 8, 2023 -- For women with breast cancer aged 50 years or older and three years postdiagnosis, outcomes are no worse with less frequent mammograms than annual mammograms, according to a study presented at the annual San Antonio Breast...

  • Adenotonsillectomy No Aid for Neurodevelopmental Outcomes in Children
    on 08/12/2023 at 9:45 pm

    FRIDAY, Dec. 8, 2023 -- In children with mild sleep-disordered breathing (SDB), adenotonsillectomy does not significantly improve executive function or attention, according to a study published in the Dec. 5 issue of the Journal of the...

  • Geographic Variability Seen in County-Level Preterm Birth Rates
    on 08/12/2023 at 9:41 pm

    FRIDAY, Dec. 8, 2023 -- Considerable geographic variability is seen in county-level preterm birth rates, according to a study published online Dec. 8 in JAMA Network Open.Sadiya S. Khan, M.D., from the Northwestern University Feinberg School of...

  • First Gene-Editing Therapies for Sickle Cell Disease Approved by FDA
    on 08/12/2023 at 9:39 pm

    FRIDAY, Dec. 8, 2023 -- Two milestone gene therapies for sickle cell disease have been approved by the U.S. Food and Drug Administration.Casgevy is the first medicine available in the United States to treat a genetic disease using the CRISPR...

  • CDC: Number of Cantaloupe-Related Salmonella Cases Has Doubled
    on 08/12/2023 at 9:35 pm

    FRIDAY, Dec. 8, 2023 -- U.S. health officials reported Thursday that the number of cases of cantaloupe-related Salmonella has doubled."Since the last update [on] Nov. 30, 2023, an additional 113 people infected with this outbreak strain of...

  • FDA Approves Landmark Sickle Cell Gene Therapies, Casgevy and Lyfgenia
    on 08/12/2023 at 5:12 pm

    FRIDAY, Dec. 8, 2023 -- The U.S. Food and Drug Administration on Friday approved two milestone gene therapies for sickle cell disease, including the first treatment ever approved that uses gene-editing technology. Casgevy, developed by Vertex...

Theme by Out the Box
  • News
  • Blog Zone
  • Contact